Table 1.
References | Study population | Tissues | Sample size | Associated ocular disease | % |
---|---|---|---|---|---|
Sevel and Sealy31 | Cape Town, South Africa | pterygia | n = 100 | squamous cell carcinoma | 12 |
carcinoma in situ | 17 | ||||
Clear et al17 | Malawi | pinguecula and pterygia | n = 167 | hyperplasia or mild dysplasia | 75.4 |
moderate dysplasia | 11.4 | ||||
carcinoma in situ | 12.6 | ||||
Erie et al34 | Mayo Clinic, Minnesota | pterygia | n = 92 | carcinoma in situ | 9.8 |
Perra et al33 | Ecuador | pterygia | n = 80 | PAM without atypia | 6.3 |
PAM with atypia | 2.5 | ||||
nevi | 2.5 | ||||
Hirst et al32 | Queensland, Australia | pterygia | n = 533 | OSSN | 9.8 |
PAM, primary acquired melanosis; OSSN, ocular surface squamous neoplasia.